Literature DB >> 19335550

Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA.

Yuri Chaves Martins1, Mary Jane Smith, Marcelo Pelajo-Machado, Guilherme Loureiro Werneck, Henrique Leonel Lenzi, Claudio Tadeu Daniel-Ribeiro, Leonardo José de Moura Carvalho.   

Abstract

Plasmodium berghei ANKA (PbA) infection in susceptible inbred mouse strains is the most commonly used experimental model to study pathogenesis of cerebral malaria (CM). Indeed, many concepts on mechanisms related to this complication have arisen from works using this model. Although inbred strains present several advantages and are indicated for most studies, the use of outbred models can show unique usefulness in a number of approaches such as fine post-quantitative trait loci mapping and discovery of genes relevant to CM susceptibility or resistance, as well as pharmacological and vaccine studies. Here we describe the features of PbA infection and CM incidence, and characterize the associated multiorgan pathology in the outbred Swiss Webster mouse. This model showed a sizeable (62.7%) and reproducible incidence of CM demonstrated by clinical signs and histopathological changes in brain (microhaemorrhages, oedema and vessel plugging by mononuclear cells). Major pathological changes were also observed in lungs, liver, thymus and spleen, analogous to those observed in inbred strains. Parasitaemia levels were associated with the risk of CM development, the risk being significantly higher in mice showing higher values of parasitaemia on days 6-7 of infection. This outbred CM model is then suitable for genetic, vaccine and drug studies targeting this malaria complication.

Entities:  

Mesh:

Year:  2009        PMID: 19335550      PMCID: PMC2676703          DOI: 10.1111/j.1365-2613.2008.00622.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  66 in total

Review 1.  QTL analysis for discovery of genes involved in drug responses.

Authors:  Saunak Sen; Michael Ferdig
Journal:  Curr Drug Targets Infect Disord       Date:  2004-03

2.  Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria.

Authors:  Irene Gramaglia; Peter Sobolewski; Diana Meays; Ramiro Contreras; John P Nolan; John A Frangos; Marcos Intaglietta; Henri C van der Heyde
Journal:  Nat Med       Date:  2006-11-12       Impact factor: 53.440

3.  Role of immune complexes in cerebral malaria.

Authors:  N Gupta; R Sehgal; R C Mahajan; A K Banerjee; N K Ganguly
Journal:  Pathology       Date:  1988-10       Impact factor: 5.306

4.  Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration.

Authors:  Blandine Franke-Fayard; Chris J Janse; Margarida Cunha-Rodrigues; Jai Ramesar; Philippe Büscher; Ivo Que; Clemens Löwik; Peter J Voshol; Marion A M den Boer; Sjoerd G van Duinen; Maria Febbraio; Maria M Mota; Andrew P Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

Review 5.  Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Authors:  J Lou; R Lucas; G E Grau
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.

Authors:  Ana Pamplona; Ana Ferreira; József Balla; Viktória Jeney; György Balla; Sabrina Epiphanio; Angelo Chora; Cristina D Rodrigues; Isabel Pombo Gregoire; Margarida Cunha-Rodrigues; Silvia Portugal; Miguel P Soares; Maria M Mota
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

Review 7.  The pathophysiology of falciparum malaria.

Authors:  Ian A Clark; William B Cowden
Journal:  Pharmacol Ther       Date:  2003-08       Impact factor: 12.310

8.  Hepatic changes in P. falciparum malaria.

Authors:  S K Mishra; S Mohanty; B S Das; J K Patnaik; S K Satpathy; D Mohanty; T K Bose
Journal:  Indian J Malariol       Date:  1992-09

9.  Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver.

Authors:  Ana C A X De-Oliveira; Anndressa C Da-Matta; Francisco J R Paumgartten
Journal:  Exp Parasitol       Date:  2006-03-15       Impact factor: 2.011

10.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05
View more
  32 in total

1.  Murine cerebral malaria: how far from human cerebral malaria?

Authors:  Leonardo J M Carvalho
Journal:  Trends Parasitol       Date:  2010-03-23

2.  Histopathological studies in two strains of semi-immune mice infected with Plasmodium berghei ANKA after chronic exposure.

Authors:  Gideon Kofi Helegbe; Tetsuo Yanagi; Masachika Senba; Nguyen Tien Huy; Mohammed Nasir Shuaibu; Akiko Yamazaki; Mihoko Kikuchi; Michio Yasunami; Kenji Hirayama
Journal:  Parasitol Res       Date:  2010-10-27       Impact factor: 2.289

3.  A chronic scheme of cranial window preparation to study pial vascular reactivity in murine cerebral malaria.

Authors:  Peng Kai Ong; Diana Meays; John A Frangos; Leonardo J M Carvalho
Journal:  Microcirculation       Date:  2013-07       Impact factor: 2.628

4.  Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.

Authors:  Adriana A Marin; Oscar Murillo; Rodrigo A Sussmann; Luana S Ortolan; Daniella S Battagello; Thatyane de Castro Quirino; Jackson C Bittencourt; Sabrina Epiphanio; Alejandro M Katzin; Leonardo J M Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

5.  Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.

Authors:  Pedro Cabrales; Graziela M Zanini; Diana Meays; John A Frangos; Leonardo J M Carvalho
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

6.  Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.

Authors:  Yuri C Martins; Brandi D Freeman; Oscar B Akide Ndunge; Louis M Weiss; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Am J Pathol       Date:  2016-09-15       Impact factor: 4.307

7.  Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol.

Authors:  Yuri C Martins; Guilherme L Werneck; Leonardo J Carvalho; Beatriz P T Silva; Bruno G Andrade; Tadeu M Souza; Diogo O Souza; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2010-03-24       Impact factor: 2.979

Review 8.  Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria?

Authors:  Blandine Franke-Fayard; Jannik Fonager; Anneke Braks; Shahid M Khan; Chris J Janse
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

9.  Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents.

Authors:  Jasmina Saric; Jia V Li; Jonathan R Swann; Jürg Utzinger; Gail Calvert; Jeremy K Nicholson; Stephan Dirnhofer; Maggie J Dallman; Magda Bictash; Elaine Holmes
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

10.  Schistosoma mansoni infection reduces the incidence of murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Daniel Gold; Ariel Ohayon; Eliezer Flescher; Alina Heyfets; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; Jacob Golenser
Journal:  Malar J       Date:  2010-01-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.